Survival in 31 670 patients with thin melanomas: a Swedish population-based study.
Karolin IsakssonR MikiverHanna ErikssonJ LapinsKari NielsenC IngvarJ LythPublished in: The British journal of dermatology (2020)
MSS was confirmed as excellent for patients with thin CMMs in Sweden. Although we could show a decreased MSS for patients with 0·7 mm thickness and above, the long-term survival and, in addition, a very favourable CMSS for those patients do not support more extended follow-up programmes than the current recommendations in Sweden.